Genetic Testing Market to Reach $28.24 Billion by 2030
According to a new market
research report titled, 'Genetic Testing Market by
Offering (Consumables, Reagents, Instruments, Services), Test Type (Diagnostic,
Prenatal, Carrier, Newborn, Preimplantation), Method (Molecular, Chromosomal),
End User (Hospitals, Diagnostic Laboratories) - Global Forecast to
2030,' published by Meticulous Research®,
the genetic testing market is projected to reach $28.24 billion by 2030, at a
CAGR of 10.4% from 2023 to 2030.
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5370
Genetic testing is done to
look at changes in the DNA, sometimes called variants or mutations, that can
lead to chronic diseases. It provides crucial information that can help
predict, diagnose, and treat diseases and plays a vital role in determining the
risk of certain inherited diseases. Genetic testing is performed for different
reasons, including pre-symptomatic and predictive testing, pharmacogenetics,
diagnostic testing, carrier testing, prenatal testing, preimplantation testing,
and newborn screening.
Genetic testing has applications
in different areas of healthcare and has various advantages, such as
determining the likelihood of parents passing the genetic mutation to their
offspring. Genetic tests are also performed prenatally or post-birth to identify
various disorders in newborns, such as organic acid metabolism disorders, amino
acid metabolism disorders, hemoglobin disorders, endocrine disorders, fatty
acid oxidation disorders, cystic fibrosis, congenital heart disease, glaucoma,
Fragile X syndrome, and down syndrome. Genetic testing is also done for the
identification of tumor genomes in cancer patients.
The genetic testing market is
segmented by offering (consumables & reagents, instruments, and services),
test type (prenatal testing, predictive and presymptomatic testing, diagnostic
testing, carrier testing, newborn screening, and preimplantation testing),
method (molecular tests, chromosomal tests, and biochemical tests), end user
(hospitals & clinics, diagnostic laboratories, and other end users), and
geography. The study also evaluates industry competitors and analyzes their
market shares at the global and regional levels.
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5370
Based on offering, in 2023,
the consumables & reagents segment is expected to account for the largest
share of the market. The large market share of this segment is attributed to
the growing need for consumables & reagents in pharmacogenomics, increasing
frequencies of screening tests, rise in the number of genetic testing labs, and
product launches by key market players. In addition to this, laboratories'
increasing capacity to perform multiple tests at the same time is expected to
trigger the need for consumables & reagents.
Based on test type, in 2023, the
prenatal testing segment is expected to account for the largest share of this
market. The increasing prevalence of congenital disabilities and awareness
about the advantages of prenatal testing among the general population and
doctors are increasing the demand for prenatal testing. Additionally, prenatal
testing is currently the best way to understand the genetic risk associated
with an infant's health. Due to this, its use is increasing rapidly in
developed and developing countries.
Based on method, in 2023, the
molecular tests segment is expected to account for the larger share of this
market. The largest market share of this segment is attributed to factors such
the increased government funding for innovation in molecular testing, increased
research activities by genetic testing companies, and the rise in cases of rare
diseases worldwide, leading to demand for molecular testing.
Quick Buy – Genetic Testing Market Research Report: https://www.meticulousresearch.com/Checkout/33822956
Based on end user, in 2023,
the hospitals & clinics segment is expected to account for the largest
share of this market. The large market share of this segment is attributed to
factors such as the availability of advanced tests and devices, high rates of
hospitalizations in cases of cancer and related rare diseases, and government
and private insurance schemes for healthcare in developed and developing
countries.
Based on geography, the genetic
testing market is segmented into five major regions: North America, Europe, Asia-Pacific, Latin America,
and the Middle
East & Africa, with a further analysis of
major countries in these regions. In 2023, North America is expected to
account for the largest share of the genetic testing market, followed by Europe, Asia-Pacific, Latin America,
and the Middle
East & Africa. Key factors such as high
healthcare expenditure, favorable reimbursement scenario, awareness among
patients about the advantages of genetic testing, and increased supports and
investments for enhancing genome sequencing infrastructure are some of the factors
primarily contributing to the larger share of this region in the genetic
testing market.
However, Asia-Pacific is
projected to register the highest CAGR over the forecast period. The rapid
expansion of the market in this region results from high investments in the
healthcare sector, increasing affordability of genetic testing, high prevalence
of rare diseases, a large pool of geriatric population, and growing adoption of
advanced genomics technologies.
Some of the key players
dominating this market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc.
(U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), OPKO Health Inc.
(U.S.), Natera, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Myriad Genetics, Inc.
(U.S.), Centogene N.V. (Germany),
Konica Minolta, Inc. (Japan),
Fulgent Genetics, Inc. (U.S.), and Laboratory Corporation of America Holdings
(U.S.).
To gain more insights into the market with a detailed table of content and
figures, click here: https://www.meticulousresearch.com/product/genetic-testing-market-5370
Scope of the Report:
Genetic
Testing Market, by Offering
- Consumables
& Reagents
- Instruments
- Services
Genetic
Testing Market, by Test Type
- Prenatal
Testing
- Predictive
and Presymptomatic Testing
- Diagnostic
Testing
- Newborn
Screening
- Carrier
Testing
- Preimplantation
Testing
Genetic
Testing Market, by Method
- Molecular
Tests
- Chromosomal
Tests
- Biochemical
Tests
Genetic
Testing Market, by End User
- Hospitals
& Clinics
- Diagnostic
Laboratories
- Others
End Users
(Other End Users Include Academic
& Research Institutes, Pharmaceutical & Biotechnology Companies, And
Contract Research Organizations)
Genetic
Testing Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest
of Europe (RoE)
- Asia Pacific
- China
- Japan
- India
- Rest
of APAC (RoAPAC)
- Latin America
- Middle East & Africa
Download Free
Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5370
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment